Home > Boards > US Listed > Medical - Drugs >

Merck & Co. Inc. (MRK)

MRK RSS Feed
Add MRK Price Alert      Hide Sticky   Hide Intro
Moderator: DewDiligence
Search This Board: 
Last Post: 5/17/2022 10:56:06 AM - Followers: 60 - Board type: Free - Posts Today: 0
MRK
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
MRK News: Merck Receives Positive EU CHMP Opinion for KEYTRUDA® (pembrolizumab) as Adjuvant Treatment for Adult and Adolescent (=12 Years of Age) Patients With Stage IIB or IIC Melanoma Following Complete Resection 05/20/2022 04:15:00 AM
MRK News: Notice of Exempt Solicitation. Definitive Material. (px14a6g) 05/13/2022 10:33:47 AM
MRK News: Merck To Present Data at 2022 ASCO Annual Meeting Highlighting Promising Pipeline Medicines and Significant Progress in Treating Earlier Stages of Certain Cancers With KEYTRUDA® (pembrolizumab) 05/10/2022 02:45:00 AM
MRK News: Statement of Changes in Beneficial Ownership (4) 05/05/2022 01:47:46 PM
MRK News: Statement of Changes in Beneficial Ownership (4) 05/05/2022 01:39:45 PM
PostSubject
#823   MRK 1Q22 results: DewDiligence 04/28/22 08:54:28 AM
#822   CHMP approves Keytruda/chemo in the neoadjuvant setting followed DewDiligence 04/25/22 10:32:50 AM
#821   MRK’s V116—(follow-on_to Vaxneuvance)—receives FDA BTD for prevention of DewDiligence 04/14/22 09:59:20 AM
#820   MRK—Vaxneuvance sBLA for pediatrics gets 3-month extension to 7/1/22: DewDiligence 04/01/22 10:28:04 AM
#819   FDA approves Keytruda monotherapy for recurrent endometrial cancer DewDiligence 03/21/22 05:47:34 PM
#818   Thanks DewDiligence. The reason I ask, is that Just the facts maam 03/20/22 06:47:29 AM
#817   Keytruda monotherapy-vs-placebo DFS HR=0.76 in adjuvant* NSCLC, irrespective DewDiligence 03/17/22 05:08:39 PM
#816   That’s a clerical error. DewDiligence 03/17/22 09:15:48 AM
#815   Upon looking at Merck's Pipeline webpage I see Just the facts maam 03/17/22 03:51:47 AM
#814   COVID SCAM IS OVER... ALL THESE GRIFTER COMPANIES Agoura Guy 02/11/22 08:23:57 PM
#813   MRK 4Q21 CC slides: DewDiligence 02/03/22 12:39:23 PM
#812   MRK 4Q21 results: DewDiligence 02/03/22 10:41:31 AM
#811   BIG PHARMA INCLUDING MERCK IN TROUBLE WITH NEW Agoura Guy 01/08/22 04:52:33 PM
#810   India Won't Add Merck's COVID-19 Pill To National Agoura Guy 01/06/22 01:04:05 PM
#809   BIG PHARMA RELYING UPON FRAUDULENT COVID-19 PCR TESTING Agoura Guy 01/03/22 12:53:36 PM
#808   MERCK IS LATE TO THE PARTY, WITHOUT 94% Agoura Guy 01/03/22 12:36:22 PM
#807   ISN'T IT INTERESTING HOW BIG PHARMA IS TAKING Agoura Guy 01/03/22 12:31:54 PM
#805   FDA grants EUA for MRK’s Molnupiravir—with_a_major_limitation: DewDiligence 12/23/21 09:54:33 AM
#804   Merck’s New Covid Pill Is a Disaster Stock_Barber 12/18/21 10:12:31 AM
#803   Any time I see the term "PCR-confirmed Covid Stock_Barber 12/18/21 09:55:49 AM
#802   A study published this week by researchers at Lowjack 12/18/21 06:40:13 AM
#801   Did anyone else see the news approval in Denmark? kayoboi 12/16/21 09:54:29 AM
#800   Bah... what's a little cancer or a bunch Stock_Barber 12/14/21 01:46:14 PM
#799   NY Times Casually Admits New FDA-Approved Merck COVID Agoura Guy 12/14/21 01:13:51 PM
#798   Re: MRK’s Islatravir safety DewDiligence 12/13/21 05:53:23 PM
#797   FDA places clinical hold on all Islatravir studies: DewDiligence 12/13/21 05:53:07 PM
#796   Amen! Stock_Barber 12/07/21 10:27:48 AM
#795   Just ship the Ivermectin and we can all Lowjack 12/07/21 06:01:55 AM
#794   FDA approves Keytruda monotherapy in adjuvant melanoma: DewDiligence 12/03/21 06:56:28 PM
#793   Vaxneuvance pediatric sBLA has 4/1/22 PDUFA (with FDA DewDiligence 12/01/21 09:04:06 AM
#792   I sure wouldn't... and will discourage everyone I Stock_Barber 11/30/21 06:50:24 PM
#791   It was a close vote. I doubt many DewDiligence 11/30/21 06:23:26 PM
#790   FDA advisers vote to recommend emergency use authorization erik007tc 11/30/21 05:34:49 PM
#789   Re: Observed fall-off in Molnupiravir efficacy DewDiligence 11/30/21 12:03:34 PM
#788   Merck's COVID-19 pill significantly less effective in new analysis Stock_Barber 11/26/21 04:50:53 PM
#787   Merck’s new COVID drug, Molnupiravir, is dangerous and unproven Stock_Barber 11/22/21 05:08:34 PM
#786   FDA approves Keytruda monotherapy in adjuvant RCC: DewDiligence 11/18/21 09:55:38 AM
#785   Guilt by association! Lowjack 11/10/21 07:51:26 AM
#784   FDA to meet with MRK for its COVID xZx 11/08/21 01:41:15 PM
#783   AS I SAID BEFORE "Cancer causing Molnupiravir is Agoura Guy 11/05/21 01:45:46 PM
#782   See the news on PFE. Stock_Barber 11/05/21 12:15:20 PM
#781   Was there news that caused that drop? rynlrt 11/05/21 11:10:15 AM
#780   I had a TON of puts that would Stock_Barber 11/05/21 10:29:07 AM
#779   I bailed @ 89 but hope to grab retired early 11/05/21 10:21:41 AM
#778   TIMMMMMBBBBBBEEEEEERRRRRRR!!!!!!!! Stock_Barber 11/05/21 09:01:21 AM
#777   Thanks for the tip. Freed 11/04/21 08:06:37 AM
#775   betting MRK $90 calls, 11/5 exp, start to xZx 11/01/21 01:55:03 PM
#774   $$$$$$$$$100 today 5-7 billion in COVID revenue alone stocky101 10/28/21 09:44:33 AM
#773   MRK 3Q21 PR and CC slides: DewDiligence 10/28/21 08:40:03 AM
#772   Sure... who cares about cancers... THERE IS MONEY Stock_Barber 10/24/21 12:22:49 AM
PostSubject
Consent Preferences